全球心血管修复和重建市场 – 行业趋势和 2029 年预测

市场分析和规模

根据 Grand View Research 的调查，全球心血管修复和重建设备市场规模预计到 2025 年将达到 44.815 亿美元。在预测期内，先天性心脏缺陷 (CHD) 的增加以及技术增强的心血管瓣膜、移植物和补片的可用性可能会推动增长。

Data Bridge Market Research 分析，心血管修复和重建市场在 2021 年为 37.2 亿美元，到 2029 年将飙升至 60.6 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 6.30%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

Heart disorders such as congenital heart disease, coronary artery disease, and arrhythmias are examples of cardiovascular diseases. Blockages in blood arteries can cause chest discomfort and heart attacks. Men are more likely than women to have chest discomfort as a symptom of cardiovascular disease, whereas women may experience symptoms such as excessive exhaustion, shortness of breath, and nausea. Blockages in arteries and veins are removed using cardiovascular reconstruction devices.

Cardiovascular Repair and Reconstruction Market Dynamics

Drivers

• Rise in cardiac diseases

According to the American Heart Association, cardiovascular diseases (CVDs) were a leading cause of death in the United States in 2015, accounting for approximately 800,000 fatalities. In the United States, about 85.6 million people are affected by the effects of a stroke or another type of CVD. It is one of the leading causes of death in the world. CVDs claimed the lives of almost 17.7 million individuals in 2015, accounting for roughly 31% of all fatalities worldwide. Mild CHD is becoming more common in the United States. Over a quarter of babies with CHD develop catastrophic CHD in their first year, which requires surgery or medication to cure. As a result, the cardiovascular repair and reconstruction market is expected to increase significantly throughout the forecast period.

• Technological advancements

New technologically advanced products, product designs, raw material procurement, raw material production, clinical evaluation, preservation solutions, and preservation procedures have all been produced. Consider the usage of ePTFE in the fabrication of cardiovascular patches by Gore Medical. ePTFE patches are strengthening the cardiovascular repair and reconstruction industry as their use for various cardiovascular repair devices grows.

• Improvement of cryopreservation procedures

Cryopreservation procedures that are technologically improved also contribute to the growth of the cardiovascular repair devices market. They aid in preserving raw materials collected from animal tissues for a longer period of time, which is critical in extending their life cycle. These technological advancements are helping to drive market growth by increasing demand for cardiovascular grafts and patches.

Opportunities

Tissue valve demand has increased since the introduction of transcatheter valves. TAVI (Transcatheter Aortic Valve Implantation) or TAVR (Transcatheter Aortic Valve Replacement) is an FDA-approved procedure for treating symptomatic aortic stenosis with a heart valve replacement. The TAVR market is dominated by established players like Edwards Lifesciences and Medtronic. In addition, JenaValve, a German business, successfully enrolled for the CE mark study for the next-generation JenaValve Pericardial TAVR system in April 2018, and is planning a restricted launch in a select European areas and countries compatible with the CE mark in the coming quarters. In the next years, new companies with innovative technologies will significantly enhance market growth.

Restraints/Challenges

The danger of skin infections is predicted to impede market expansion throughout the forecast period. The high cost of cardiovascular repair and reconstruction products and a lack of understanding about microbe-derived items are predicted to hinder market expansion over the forecast period of 2022 to 2029.

This cardiovascular repair and reconstruction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiovascular repair and reconstruction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Cardiovascular Repair and Reconstruction Market

During the first half of 2020, the COVID-19 had a negative impact on the worldwide cardiovascular surgical devices business. The World Health Organization recognized the emergence of healthcare with the outbreak of Covid-19 (WHO). Furthermore, the governments instituted a nationwide lockdown and a flight restriction. Furthermore, cardiac surgery activities were halted and postponed due to the unexpected shutdown, causing the market to fall. However, the market has grown significantly in the aftermath of the pandemic. Furthermore, heart surgery usage has increased, and the market has grown at the fastest rate. With the arrival of the year 2021, market shares are predicted to increase on average.

Recent Development

• In October 2020, GE Healthcare got FDA 510k clearance for its ultra-edition bundle of vivid cardiovascular ultrasound devices, which includes new AI-based capabilities that allow doctors to consistently obtain faster, more reproducible assessments.

Global Cardiovascular Repair and Reconstruction Market Scope

The cardiovascular repair and reconstruction market is segmented on the basis of product, raw material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Heart Valve Repair
• Cardiovascular Grafts
• Endovascular stent graft
• Hemodialysis access graft
• Peripheral vascular graft
• Cardiovascular Patches

 Application

• Cardiac repair patches
• Atrial septal defect
• Common atrium
• Defects of the endocardial cushion
• Ventricular septal defect
• Tetralogy of Fallot
• Suture bleeding
• Vascular Repair Patches
• Carotid endarterectomy
• Anomalous connection of the pulmonary veins
• Transportation of the great vessels
• Reconstruction of the portal and superior mesenteric veins
• Others

Raw Material

• Synthetic patches
• Biological patches

Cardiovascular Repair and Reconstruction Market Regional Analysis/Insights

The cardiovascular repair and reconstruction market is analysed and market size insights and trends are provided by country, product, raw material and application as referenced above.

The countries covered in the cardiovascular repair and reconstruction market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the global cardiovascular repair and reconstruction market. Because of the ageing population and bad lifestyle, cardiovascular illnesses are prevalent.

Asia-Pacific is expected to witness the fastest growth over the forecast period. Due to their vast populations, ageing populations, high unmet healthcare requirements, and changing lifestyles, China, India, and other growing nations in the region are at the forefront. Improvements in the region's healthcare infrastructure are also helping to drive the market forward.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和心血管修复与重建市场份额分析

心血管修复和重建市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对心血管修复和重建市场的关注有关。

心血管修复和重建市场的一些主要参与者包括：

• CryoLife, Inc.（美国）
• 爱德华生命科学公司（美国）
• 巴德外周血管科（美国）
• 百特（美国）
• Anteris（美国）
• Neovasc Inc.（加拿大）
• Southernlight Biomaterials（新西兰）
• 美敦力（爱尔兰）
• GETINGE AB（瑞典）
• 戈尔公司 (美国)
• 雅培（美国）
• LeMaitre Vascular Inc.（美国）
• BioIntegral Surgical（加拿大）
• 美国实验室控股公司（美国）
• 泰尔茂医疗公司（美国）
• Perouse Medical（法国）
• 郡士有限公司 (美国)
• Maverick Biosciences（美国）

SKU-68650